Ambu leadership under scrutiny for communication style
The top management of medical company Ambu is being criticized for not openly discussing the company's challenges.
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN
Danish medical technology company Ambu's top management declines to comment the big stock purchase made by CEO Juan Jose Gonzales upon request from domestic business daily Børsen. Last week, Gonzales bought shares worth USD 4.1m (DKK 26m) in the medtech firm.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Pentax rejects Ambu's claims of head start
For subscribers
Analyst: Pentax partnership might lead Ambu to new market
For subscribers
